6/18/2023 Flashcards
Quetiapine MOA
Mixed 5-HT2A and D2 antagonism, results in:
Reduced DA activity in the mesolimbic pathway and reduced positive symptoms
Increased DA release from 5-HT2A antagonism in the mesocortical pathway and reduced negative symptoms
Increased DA release from 5-HT2A antagonism in the nigrostriatal pathway and less risk of EPS
Increased DA release from 5-HT2A antagonism in the tuberoinfundibular pathway and less risk for hyperprolactinemia
Quetiapine class
Second generation antipsychotic
AcipHex
Rabeprazole
Rabeprazole class
PPI
Elitek
Rasburicase
Rasburicase MOA
Rasburicase is a recombinant urate-oxidase enzyme, which converts uric acid to allantoin (a soluble metabolite of uric acid).
Rasburicase class
recombinant urate oxidase enzyme
Veklury
Remdesivir
Remdesivir MOA
Inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication. Remdesivir gets phosphorylated and acts as a nucleotide to get incorporated into RNA, resulting in chain termination during RNA replication.
Rifadin
Rifampin
Rifampin MOA
Inhibits bacterial RNA synthesis by binding to the beta subunit of DNA-dependent RNA polymerase, blocking RNA transcription
Xifaxan
Rifaximin
Rifaximin MOA
Inhibits bacterial RNA synthesis by binding to bacterial DNA-dependent RNA polymerase
Risperidone MOA
Mixed 5-HT2A and D2 antagonism, results in:
Reduced DA activity in the mesolimbic pathway and reduced positive symptoms
Increased DA release from 5-HT2A antagonism in the mesocortical pathway and reduced negative symptoms
Increased DA release from 5-HT2A antagonism in the nigrostriatal pathway and less risk of EPS
Increased DA release from 5-HT2A antagonism in the tuberoinfundibular pathway and less risk for hyperprolactinemia
Risperidone class
Second generation antipsychotic
Rituximab MOA
Monoclonal antibody targeted against CD20 antigen on the surface of B cells. Rituximab binds to CD20 and initiates complement-dependent cytotoxicity.
Rituximab class
monoclonal antibody, anti-CD20; antirheumatic; antineoplastic
Maxalt
Rizatriptan
Rizatriptan MOA
Selective serotonin agonist at 5-HT1B and 5-HT1D receptors in cranial arteries. Causes vasoconstriction and reduces inflammation associated with migraine.
Rizatriptan class
serotonin 5-HT1B ,1D receptor agonist
Nplate
Romiplostim
Romiplostim MOA
Thrombepoietin (TPO) peptide mimetic that increases platelet counts in ITP by binding to and activating the human TPO receptor
Romiplostim class
Colony stimulating factor; thrombopoietic agent
Ropinirole MOA
Dopamine agonist; higher affinity for D3 than D2 and D4.
Ropinirole class
anti-Parkinson agent; dopamine agonist
Senna MOA
Induces defecation by stimulating peristaltic activity on the intestine by direct action on the intestinal mucosa or nerve plexus, therefore increasing motility
Sovaldi
Sofosbuvir
Sofosbuvir MOA
Direct-acting antiviral agent against the hepatitis C virus; Inhibits HCV NS5B RNA-dependent RNA polymerase, essential for viral replication, and acts as a chain terminator.
Sofosbuvir class
Anti-HCV polymerase inhibitor; NS5B RNA polymerase inhibitor
St. John’s Wort
Hypericum Perforatum
Sucralfate MOA
Forms a complex by binding with positively charged proteins in exudates, forming a viscous paste-like, adhesive substance. This selectively forms a protective coating that acts locally to protect the gastric lining against peptic acid, pepsin, and bile salt.
Sucralfate class
Miscellaneous GI agent
Imitrex
Sumatriptan
Sumatriptan MOA
Selective agonist for serotonin (5-HT1B and 5-HT1D) receptors on intracranial blood vessels and sensory nerves of the trigeminal system; causes vasoconstriction and reduces inflammation associated with migraine.
Sumatriptan class
serotonin 5-HT1B and 5-HT1D agonist
Prograf
Tacrolimus
Tacrolimus MOA
Binds to FKPB-12 (intracytosolic protein) resulting in decreased IL-2 production and therefore decreased T-cell production
Tacrolimus class
calcineurin inhibitor
Envarsus
Tacrolimus
Astagraf
Tacrolimus